Skip to main content

Serotonin — der wichtigste Neurotransmitter des Menschen?

  • Conference paper
  • 23 Accesses

Zusammenfassung

Die expansive Kollateralisierung aufsteigender serotonerger Axone aus den oberen Raphekernen (Steinbusch 1981) und die erhebliche Innervationsdichte in vielen telodienzephalen Zielgebieten (Lidov et al. 1980; Foote u. Morrison 1987; Berger et al. 1988; Lavoie u. Parent 1990) läßt vermuten, daß Sero tonin bedeutende Einflüsse auf praktisch alle zentralen Regulationssysteme ausüben kann (Vogt 1982). Serotonin ist kein Exekutivtransmitter in Hauptfunktionsschleifen des ZNS, sondern ein übergeordneter Modulator, der die Arbeitsweise anderer retikulärer Neurotransmittersysteme (cholinerg, noradrenerg, dopaminerg) an die Erfordernisse der Vigilanzsteuerung im Schlaf-Wach-Zyklus anpaßt und den Durchsatz von Sinnessystemafferenzen durch komplexe Netzwerke und den Durchschlag von motorischen und nichtmotorischen (assoziativen) Exekutivsystemen (glutamaterg, aspartaterg) in Haupterregungsschleifen kontrolliert (Baumgarten u. Lachenmayer 1985; Baumgarten 1991). Wir haben diese Eigenschaft des aufsteigenden Serotoninsystems als protektive Filterfunktion bezeichnet, die bedeutungslose Informationsmuster (Störgrößen) eliminiert, aber verhaltensrelevante, wichtige Afferenzmuster bahnt (über bedarfsgerechte Änderungen des Gleichgewichts hemmender und fördernder Einflüsse des Serotoninsystems an Zielneuronen).

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Agren H (1983) Depression and altered neurotransmission - states, traits, and interactions. In: Angst J (ed) The Origins of depression: Current concepts and approaches. Dahlem Konferenzen. Springer, Berlin Heidelberg New York Tokyo, pp 297–311

    Google Scholar 

  • Apter A, Praag HM van, Plutchik R, Sevy S, Korn M, Brown S-L (1990) Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res 32:191–199

    PubMed  CAS  Google Scholar 

  • Araneda R, Andrade R (1991) 5-Hydroxytryptamine-2 and 5-hydroxytryptamine-l A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40:412

    Google Scholar 

  • Aston-Jones G, Akaoka H, Charléty P, Chouvet G (1991) Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neuroscience 11:760–769

    CAS  Google Scholar 

  • Azmitia EC, Gannon PJ (1986) The primate serotonergic system: A review of human and animal studies and a report on macaca fascicularis. Adv Neurol 43:407–468

    PubMed  CAS  Google Scholar 

  • Balon R (1990) Buspirone for attention deficit hyperactivity disorder? J Clin Psychopharmacol 10/1:77

    PubMed  CAS  Google Scholar 

  • Bassant MH, Ennouri K, Lamour Y (1990) Effects of iontophoretically applied monoamines on somatosensory cortical neurons of unanesthetized rats. Neurosci 39/2:431–439

    CAS  Google Scholar 

  • Baumgarten HG (in Vorbereitung) Neuroanatomie und Neurophysiologie des zentralen Serotoninsystems. In: Heinrich K, Hippius H, Pöldinger W (eds) Serotonin : Ein funktioneller Ansatz für die psychiatrische Diagnose und Therapie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Baumgarten HG, Lachenmayer L (1985): Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatry 18:180–187

    PubMed  CAS  Google Scholar 

  • Baumgarten HG, Bjorklund A, Lachenmayer L, Nobin A (1973) Evaluation of the effects of 5,7-dihydroxy-tryptamine on serotonin and catecholamine neurons in the rat CNS. Acta Physiol Scand Suppl 373

    Google Scholar 

  • Baumgarten HG, Björklund A, Nobin A, Rosengren E, Schlossberger HG (1975) Neurotoxicity of hydroxylated tryptamines: Structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons. Acta Physiol Scand, Suppl 429:1–27

    Google Scholar 

  • Baumgarten HG, Björklund A, Wuttke W (1978) Neural control of pituitary LH, FSH and prolactin secretion: the role of serotonin. In: Scott DE, Kozlowski GP, Weindl A (eds) Brain-Endocrine Interaction III. Neural Hormones and Reproduction. Karger, Basel, pp 327–343

    Google Scholar 

  • Baumgarten HG, Klemm HP, Sievers J, Schlossberger HG (1982) Dihydroxytriptamines as tools to study the neurobiology of serotonin. Brain Res Bull 9:131–150

    PubMed  CAS  Google Scholar 

  • Berger B, Trottier S, Verney C, Gaspar P, Alvarez C (1988) Regional and laminar distribution of the dopamine and serotonin innervation in the macaque cerebral cortex: A radioautographic study. J Comp Neur 273:99–119

    PubMed  CAS  Google Scholar 

  • Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N (1991) 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin. Acta Psychiatr Scand 83:244–248

    PubMed  CAS  Google Scholar 

  • Bevan P, Olivier B, Schipper J, Mos J (1989) Serotonergic function and aggression in animals. In: Mylecharane EJ, Angus JA, Lande IS de la, Humprey PPA (eds) Serotonin; actions, receptors, pathophysiology. Macmillan, Houndmills, Basingstoke & London, pp 101–112

    Google Scholar 

  • Biegon A (1990) Effects of steroid hormones on the serotonergic system. Ann NY Acad Sci 600:427–434

    PubMed  CAS  Google Scholar 

  • Blundell JE, Lawton CL (1990) Serotonin receptor sub-types and the organisation of feeding behaviour: experimental models. In: Paoletti R, Vanhoutte PM, Brunello N, Maggi FM (eds) Serotonin: From cellbiology to pharmacology and therapeutics, Kluwer Acad, Dordrecht Boston London, pp 213–219

    Google Scholar 

  • Boer JA den, Westenberg HGM (1990) Serotonin function in panic disorder: a double-blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 102:85–94

    Google Scholar 

  • Brewerton TD, Brandt HA, Lessem MD, Murphy DL, Jimerson DC (1990) Serotonin in obsessive-compulsive disorder. In: Coccaro E, Murphy DL (eds) Serotonin in major psychiatric disorder. American Psychiatric Press, Washington/DC, London, pp 155–184

    Google Scholar 

  • Brewerton TD, Murphy DL, Brandt HA, Lessem MD, Jimerson DC (1991) Serotonin dysregulation in bulimia nervosa. In: Brown S-L, Praag HM van (eds) The role of Serotonin in psychiatric disorders. Brunner/Mazel, New York, pp 239–259

    Google Scholar 

  • Broekkamp CL, Jenck F (1989) The relationship between various animal models of anxiety, fear-related psychiatric symptoms and response to serotonergic drugs. In: Bevan P, Cools A, Archer T (eds) Erlbaum, Behavioural pharmacology of 5-HT. Hillsdale Hove London, pp 321–335

    Google Scholar 

  • Brown GL, Linnoila MI (1990) CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry 51/4:31–43

    PubMed  Google Scholar 

  • Brown SL, Praag HM van (eds) (1991) The role of Serotonin in psychiatric disorders; clinical and experimental psychiatry. Monograph No. 4. Brunner/Mazel, New York

    Google Scholar 

  • Bruning G, Kaulen P, Schneider U, Baumgarten HG (1989) Quantitative autoradiographic distribution and pharmacological characterization of (3H) buspirone binding to sections from rat, bovine and marmoset brain. J Neural Transm (GenSect) 78:131–144

    CAS  Google Scholar 

  • Carlsson A, Svennerholm L, Winblad B (1980) Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psych Scand, Suppl 280/61:75–82

    CAS  Google Scholar 

  • Charney DS, Krystal JH, Delgado PL, Heninger GR (1990) Serotonin-specific drugs for anxiety and depressive disorders. Ann Rev Med 41:437–446

    PubMed  CAS  Google Scholar 

  • Coccaro EF (1989) Central serotonin and impulsive aggression. Br J Psychiatry 155/8:52–62

    Google Scholar 

  • Coccaro EF, Murphy DL (eds) (1990) Serotonin in major psychiatric disorders; Progress in psychiatry Series, vol 21. American Psychiatric Press, Washington London

    Google Scholar 

  • Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989) Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 46:587–598

    PubMed  CAS  Google Scholar 

  • Crow TJ, Deakin HFW (1985) Neurohumoral transmission, behaviour and mental disorder. In: Shepherd M (ed) Handbook of psychiatry. Cambridge Univ Press, Cambridge/England, part 5, pp 137–252

    Google Scholar 

  • Csernanyk JG, Poscher M, Faull KF (1990) Serotonin in schizophrenia. In: Coccaro EF, Murphy DL (eds) Serotonin in major psychiatric disorders. American Psychiatric Press, Washington London, pp 209–230

    Google Scholar 

  • Curzon G (1988) Serotonergic mechanisms of depression. Clinical neuropharmacology, vol 11, Suppl 2, pp S11-S20

    Google Scholar 

  • Curzon G, Haleem DJ, Kennett GA (1989) Neurochemical and behavioral effects of stress: A rat model of depression. In: Lerer B, Gershon S (eds) New directions in affective disorders. Springer, Berlin Heidelberg New York Tokyo, pp 5–8

    Google Scholar 

  • Dalhouse AD (1976) Social cohesiveness, hypersexuality and irritability induced by p-CPA in the rat. Physiol Behav 17:679–686

    PubMed  CAS  Google Scholar 

  • Davis M, Sheard MH (1974) Habituation and sensitisation of rat startle response: effect of raphe lesions. Physiol Behav 12:425–431

    PubMed  CAS  Google Scholar 

  • Deakin IFW (1989) 5-HT receptor subtypes in depression. In: Bevan P, Cools AR, Archer T (eds) Pharmacology of 5-HT, Erlbaum, Hillsdale Hove London, pp 179–204

    Google Scholar 

  • Deakin JFW, Wang M (1990) Role of 5-HT2 receptors in anxiety and depression. In: Paoletti P, Vanhoutte PM (eds) Serotonin from cell biology to pharmacology and therapeutics. Kluwer, Dordrecht, pp 505–509

    Google Scholar 

  • Edwards E, Harkins K (1991) 5-HTlb receptors in an animal model of depression. Neuropharmacol 30/1:101–105

    CAS  Google Scholar 

  • Eichelmann BS (1990) Neurochemical and psychopharmacologic aspects of aggressive behavior. Ann Rev Med 41:149–158

    Google Scholar 

  • Fishbein DH, Lozovsky D, Jaffe JH (1989) Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry 25:1049–1066

    PubMed  CAS  Google Scholar 

  • Foote SL, Morrison JH (1987) Extrathalamic modulation of cortical function. Ann Rec Neurosci 10:67–95

    CAS  Google Scholar 

  • Fuxe K, Agnati LF, Härfstrand A, Cintra A, Aronsson M, Zoli M, Gustafsson J-A (1988) Principles for the hormone regulation of wiring transmission and volume transmission in the central nervous system. In: Ganten D (eds) Current topics in neuroendocrinology, vol 8 Springer, Berlin Heidelberg New York Tokyo, pp 1–53

    Google Scholar 

  • Gold PW, Kling MA, Demitrack MA, Whitfield H, Kalogeras K, Louriaux DL, Chrousos GP (1988) Clinical studies with corticotropin releasing hormone: Implications for hypothalamic-pituitary-adrenal dysfunction in depression and related disorders. In: Ganten D, Pfaff D (eds) Current topics in neuroendocrinology, vol 8, Springer, Berlin Heidelberg New York Tokyo, pp 55–77

    Google Scholar 

  • Graeff FG (1984) The anti-aversive action of minor tranquilizers. Trends Pharmacol Sci 5:230–233

    CAS  Google Scholar 

  • Graeff FG (1986) 5-Hydroxytryptamine, aversion, and anxiety. Behav Brain Sci 9:339–340

    Google Scholar 

  • Green AR, Backus LI (1990) Animal models of serotonin behavior. Ann NY Acad Sci 600:237–248

    PubMed  CAS  Google Scholar 

  • Hernandez L, Hoebel BG (1988) Feeding and hypothalamic stimulation increase extracellular dopamine in the nucleus accumbens. Physiol Behav 44:599–606

    PubMed  CAS  Google Scholar 

  • Hery M, Faudon M, Dusticier G, Héry F (1982) Daily variations in serotonin metabolism in the suprachiasmatic nucleus of the rat: Influence of oestradiol impregnation. J Endocrinal 94:157–166

    CAS  Google Scholar 

  • Higley JD, Suomi SJ, Linnoila M (1990) Developmental influences on the serotonergic system and timidity in the nonhuman primate. In: Coccaro EF, Murphy DL (eds) Serotonin in Major Disorders. Am Psychiatric Press, Washington London, pp 27–46

    Google Scholar 

  • Hoebel BG, Hernandez L, McCelland RC, Schwartz D (1988) Dexfenfluramine and feeding reward. Clin Neuropharmacol 11, Suppl 1:72–82

    Google Scholar 

  • Hoebel BG, Hernandez L, Mark GP, Schwartz DH, Pothos E, Steckel JM, Stone EA (1990) Brain microdialysis as a molecular approach to obesity: serotonin, dopamine, cyclic-AMP. In: Bray GA, Riequier D, Spiegelman BM (eds) Obesity: Towards a molecular approach. Wiley Liss, New York Chichester, pp 45–61

    Google Scholar 

  • Hudson JI, Pope Jr HG (1990) Affective spectrum disorder: Does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 147/5:552–564

    PubMed  CAS  Google Scholar 

  • Jacobs BL (1987) Central monoaminergic neurons: Single-unit studies in behaving animals. In: Psychopharmacology: Meltzer HY (ed) The Third Generation of Progress. Raven, New York, pp 159–169

    Google Scholar 

  • Kahn RS, Praag HM van, Wetzler S, Asnis GM, Barr G (1988) Serotonin and anxiety revisited. Biol Psychiatry 23:189–208

    PubMed  CAS  Google Scholar 

  • Kelland MD, Freeman AS, Chiodo LA (1990) Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J Pharmacol Exp Ther 253:803–811

    PubMed  CAS  Google Scholar 

  • Kennett GA, Dickinson SL, Curzon G (1985 a) Enhancement of some 5-HT- dependent behavioural responses following repeated immobilisation in rats. Brain Res 330:253–263

    PubMed  CAS  Google Scholar 

  • Kennett GA, Dickinson SL, Curzon G (1985 b) Central serotonergic responses and behavioral adaptation to repeated immobilisation: the effect of the corticosterone systhesis inhibitor metyrapone. Eur J Pharmacol 119:143–142

    PubMed  CAS  Google Scholar 

  • Kennett GA, Chaouloff F, Marcou M et al. (1986) Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res 382:416–421

    PubMed  CAS  Google Scholar 

  • Kennett GA, Dourish CT, Ciurzon G (1987) Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharamacal 134:265–274

    CAS  Google Scholar 

  • Koe BK (1990) Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. J Clin Psychiatry 51 [12, Suppl B]: 13–17

    PubMed  Google Scholar 

  • Kosofsky BE, Molliver ME (1987) The serotonergic innervation of cerebral cortex: Different classes of axon terminals arise from dorsal and median raphé nuclei. Synapse 1:153–168

    PubMed  CAS  Google Scholar 

  • Kruse JS (1988) Destruction of suprachiasmatic nuclei serotonergic fibers alters response of hamster activity rhythms to a monoamine oxidase inhibitor. Ann Rev Chronopharm 5:131–134

    CAS  Google Scholar 

  • Lavoie B, Parent A (1990) Immunohistochemical study of the serotonergic innervation of the basal ganglia in the squirrel monkey. J Comp Neur 299: 1–16

    PubMed  CAS  Google Scholar 

  • Leibowitz SF (1988) Interaction between PVN norepinephrine, 2-noradrenergic receptors and circulating hormones: Role in the control of ingestive behavior. Neurosci Biobehav Rev 12:101–109

    PubMed  CAS  Google Scholar 

  • Leibowitz SF, Shor-Posner G, Weiss GF (1990) Serotonin in medial hypothalamic nuclei controls circadian patterns of macronutrient intake. In: Paoletti R, Vanhoutte PM, Brunello N, Maggi FM (eds) Serotonin: from cell biology to pharmacology and therapeutics. Kluwer, Dordrecht Boston London, pp 203–211

    Google Scholar 

  • Lidov HGW, Grzanna R, Molliver ME (1980) The serotonin innervation of the cerebral cortex in the rat - An immunohistochemical analysis. Neuroscience 5:207–227

    PubMed  CAS  Google Scholar 

  • Mann JJ, Arango V, Marzuk PM, Theccanat S, Reis DJ (1989) Evidence for the 5- HT hypothesis of suicide. Br J Psychiatry 155/8:7–14

    Google Scholar 

  • Markovitz PJ, Stagno SJ, Calabrese JR (1990) Buspirone augmentation of fluoxetine in obsesssive-compulsive disorder. Am J Psychiatry 147:798–800

    PubMed  CAS  Google Scholar 

  • Martin P, Soubrié P, Puech AJ (1990) Reversal of helpless behavior by serotonin uptake blockers in rats. Psychopharmacology 101:403–407

    PubMed  CAS  Google Scholar 

  • Maura G, Raiteri M (1986) Cholinergic terminals in rat hippocampus possess 5- HT1B receptors mediating inhibition of acetylcholine release. Europ J Pharmacol 129:33–337

    Google Scholar 

  • McCelland RC, Hoebel BG (1991) d-Fenfluramine and self-stimulation: loss of fenfluramine effect in underweight rats. Brain Res Bull

    Google Scholar 

  • McEwen BS (1987) Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem Pharmacol 36:1755–1763

    PubMed  CAS  Google Scholar 

  • McIntyre IM, Oxenkrug GF, Stanley M, Gershon S (1984) The effect of 5,7- dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone. Brain Res 309:156–158

    PubMed  CAS  Google Scholar 

  • Montigny C de, Chaput Y, Blier P (1990) Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51/12 [Suppl B]:4–8

    Google Scholar 

  • Murphy DL, Pigott TA (1990) A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety. J Clin Psychiatry 51/4:53–60

    PubMed  Google Scholar 

  • Nemeroff CB, Owens MJ (1989) Preclinical and clinical investigations of corticotropin -releasing factor: Assessment of its role in depressive disorders. In Lerer B, Gershon S (eds) New directions in affective disorders. Springer, Berlin Heidelberg New York Tokyo, pp 262–266

    Google Scholar 

  • Nemeroff CB, Owens MJ (1989) Preclinical and clinical investigations of corticotropin -releasing factor: Assessment of its role in depressive disorders. In Lerer B, Gershon S (eds) New directions in affective disorders. Springer, Berlin Heidelberg New York Tokyo, pp 262–266

    Google Scholar 

  • Nemeroff CB, Widerlov E, Bissette G, Wallens H, Karlsson I, Eklund K, Kilts G, Loosen P (1984) Elevated immunoreactive corticotropin releasing hormone in depressed patients. Science 244:1342–1344 Neppe VM (1989) High-dose buspirone in case of tardive dyskinesia. Lancet II:16, 1458

    Google Scholar 

  • Neppe VM (1989) High-dose buspirone in case of tardive dyskinesia. Lancet II:16, 1458

    Google Scholar 

  • Nieuwenhuys R, Voogd J, Huizen C van (1988) The human central nervous system; third revised edition. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Olivier B, Mos J (1989) Serontonergic aspects of aggressive behavior. In: Lerer B, Gershon S (eds) New directions in affective disorders. Springer Berlin Heidelberg New York Tokyo, pp 40–44

    Google Scholar 

  • Olivier B, Mos J, Tulp M, Schipper J, Bevan P (1989) Modulatory action of serotonin in aggressive behaviour. In: Bevan P, Cools AR, Archer T (eds) Behavioural pharmacology on 5-HT. Erlbaum, Hillsdale New Jersey Hove London, pp 89–115

    Google Scholar 

  • Pepin M-C, Beaulieu S, Barden N (1989) Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Mol Brain Res 6:77–83

    PubMed  CAS  Google Scholar 

  • Peroutka SJ, Schmidt AW, Sleight AJ, Harrington MA (1990) Serotonin receptor „families“ in the central nervous system: an overview. Ann NY Acad Sci 600:104–113

    PubMed  CAS  Google Scholar 

  • Porsolt RD (1989) Behavioral, despair: past and future. In: Lerer B, Gershon S (eds) New directions in affective disorders. Springer, Berlin Heidelberg New York Tokyo, pp 17–20

    Google Scholar 

  • Praag HM van, Asnis GM, Kahn RS, Brown SL, Korn M, Harkavy Friedman JM, Wetzler S (1990) Nosological tunnel vision in biological psychiatry. In: Whitaker-Azmitia PM, Peroutka SJ (eds) The Neuropharmacology of Serotonin, Ann NY Acad Sci 600:501–510

    Google Scholar 

  • Ratey JJ, Sovner R, Mikkelsen E, Chmielinski HE (1989) Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. J Clin Psychiatry 50:382–384

    PubMed  CAS  Google Scholar 

  • Robinson SE (1983) Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum. Life Sci 32:345–353

    PubMed  CAS  Google Scholar 

  • Robinson DS (1991) Antidepressant efficacy of 5-HT 1A partial agonist drugs. In: Sandler M, Coppen A, Harnett S (eds) 5-Hydroxytryptamine in Psychiatry. Oxford Univ Press, Oxford New York Tokoy, pp 158–165

    Google Scholar 

  • Schwartz D, McClane S, Hernandez L, Hoebel BG (1989 a) Feeding increases extracellular serotonin in the lateral hypothalamus of the rat as measured by microdialysis. Brain Res 479:349–354

    PubMed  CAS  Google Scholar 

  • Schwartz D, Hernandez L, Hoebel BG (1989 b) Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Res 482:261–270

    PubMed  CAS  Google Scholar 

  • Sheldon PW, Aghajanian GK (1988) Serotonin (5-HT) and norepinephrine (NE) induce IPSPs in pyramidal cells of the piriform cortex: evidence for a 5-HT2 and al activated interneuron. Soc Neurosci Abst 14:215

    Google Scholar 

  • Soubrié P (1986) Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 9:319–364

    Google Scholar 

  • Soubrié P (1988) Serotonin and behaviour, with special regard to animal models of anxiety, depression and waiting ability. In: Osborne NN, Hamon M (eds) Neuronal Serotonin. Wiley, Chichester New York Toronto Singapore, pp 255–270

    Google Scholar 

  • Steinbusch HWM (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat. Neuroscience 4:557–618

    Google Scholar 

  • Sulser F (1987) Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders. J Clin Psychiatry 48 [Suppl 3]: 12–18

    PubMed  CAS  Google Scholar 

  • Szafarczyk A, Ixart G, Malaval F, Nouguier-Soule J, Assenmacher I (1979) Effects of lesions of the suprachiasmatic nuclei and of p-chlorophenylalanine of the circadian rhythms of adrenocorticotrophic hormone and corticosterone in the plasma, and on locomotor activity in rats. J Endocrinol 83:1–16

    PubMed  CAS  Google Scholar 

  • Thomas EB, Levine ES, Arnold WJ (1968) Effects of maternal deprivation and incubation rearing upon adrenocortical activity in the adult rat. Dev Psychobiol 1:21–23

    Google Scholar 

  • Thompson PM, Zebrowski G and Neumann RS (1991) Alteration of neocortical activity in response to noxious stimulation: participation of the dorsal raphe. Neuropharmacology 30:135–141

    PubMed  CAS  Google Scholar 

  • Törk I (1990) Anatomy of the serotonergic system. In: Whitaker-Azmitia PN, Peroutka SJ (eds) The Neuropharmacology of Serotonin. Ann NY Acad Sci 600:9–35

    Google Scholar 

  • Valzelli L (1981) Psychopharmacology of aggression: an overview. Int Pharmacopsychiatry 16:39–48

    PubMed  CAS  Google Scholar 

  • Valzelli L (1984) Reflections on experimental and human pathology of aggression. Prog Neuropsychopharmacol Biol Psychiatry 8:311–325

    PubMed  CAS  Google Scholar 

  • Vanderwolf CH (1989) A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine. Brain Res 504: 192–198

    PubMed  CAS  Google Scholar 

  • Vanderwolf CH, Leung LWS (1985) Brain electrical activity in relation to behavior. In: Boulton AA, Baker GB (eds) Neuromethods, vol 1: General neurochemical techniques. Human Press, Clifton New Jersey, pp 305–341

    Google Scholar 

  • Vogt M (1982) Some functional aspects of central serotonergic neurons. In: Osborne N (ed) Biology of Serotonergic Transmission. Wiley, Chichester New York Brisbane Toronto Singapore, pp 299–315

    Google Scholar 

  • Waterhouse BD, Moises HC, Woodward DJ (1986) Interaction of serotonin with somatosensory cortical neuronal responses to afferent synaptic inputs and putative neurotransmitters. Brain Res Bull 17:507–518

    PubMed  CAS  Google Scholar 

  • Willner P (1989) Towards a theory of serotonergic dysfunction in depression. In: Bevan P, Cools AR, Archer T (eds) Behavioural pharmacology of 5-HT. Erlbaum, Hillsdale New Jersey, pp 157–177

    Google Scholar 

  • Wuttke W, Hancke LJ, Höhn KG, Baumgarten HG (1978) Effect of intraventricular injection of 5–7-dihydroxytryptamine on serum gonadotropins and prolactin. Ann NY Acad Sci 305:423–436

    PubMed  CAS  Google Scholar 

  • Zemlan FP, Garver DL (1990) Depression and antidepressant therapy: Receptor dynamics. Prog Neuropsychopharmacol Biol Psychiatry 14:503–523

    PubMed  CAS  Google Scholar 

  • Zohar J, Murphy DL, Zohar-Kadouch RC, Pato MTA, Wozniak KM, Insel TR (1990) Serotonin in obsessive-compulsive disorder. In: Coccaro EF, Murchpy DL (eds) Serotonin in major psychiatric disorders. Am Psychiatric Press, Washington London, pp 101–125

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Baumgarten, HG. (1991). Serotonin — der wichtigste Neurotransmitter des Menschen?. In: Hippius, H., Pöldinger, W. (eds) Phantasie und Wirklichkeit — Fluvoxamin. Die Reihe duphar med communication wird herausgegeben von Wolfgang Wagner und Ulrike Evers, Hannover.. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76935-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76935-1_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54551-4

  • Online ISBN: 978-3-642-76935-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics